Suchergebnisse - "Ghrieb, Zineb"

PubPharm (9)

1

Chronology of the ISO 9001:2015 certification and satisfaction survey in the multidisciplinary Clinical Investigation Center (CIC) of the historic Saint-Louis Hospital during the COVID-19 pandemic

enthalten in: Therapie | 2024

von Ghrieb, Z. | Walter-Petrich, A. | Huang, J. | +6

2

Impact of the COVID-19 pandemic on antiviral drug development for other community-acquired respiratory viruses' infections

enthalten in: Therapie | 2023

von Ghrieb, Z. | Salmona, M. | Michonneau, D. | +6

3

Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer : A Phase Ib/Phase IIa De-Escalation Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Adotévi, O. | Vernerey, D. | Jacoulet, P. | +27

4

An example of Clinical Investigations Center reorganization during the COVID-19 pandemic French national lockdown

enthalten in: Therapie | 2021

von Ghrieb, Z. | Allaoua, S. | Huang, J. | +11

5

Phase I-II Open-Label Multicenter Study of Palbociclib + Vemurafenib in BRAF V600MUT Metastatic Melanoma Patients : Uncovering CHEK2 as a Major Response Mechanism

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Louveau, B. | Resche-Rigon, M. | Lesimple, T. | +18

6

A Multicenter Phase II Study of Pazopanib in Patients with Unresectable Dermatofibrosarcoma Protuberans

enthalten in: The Journal of investigative dermatology | 2021

von Delyon, J. | Porcher, R. | Battistella, M. | +14

7

Satisfaction survey in the clinical investigations center (CIC-1427) in Saint-Louis hospital Paris, France

enthalten in: Therapie | 2021

von Dupont, A. | Chevret, S. | Montlahuc, C. | +5

8

A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Teixeira, L. | Medioni, J. | Garibal, J. | +17

CommentIn: Clin Cancer Res. 2020 Feb 1;26(3):529-531. - PMID 31796513

9

Ropeginterferon alpha-2b targets JAK2V617F-positive polycythemia vera cells in vitro and in vivo

enthalten in: Blood cancer journal | 2018

von Verger, E. | Soret-Dulphy, J. | Maslah, N. | +11

1
[1]